Abstract SAT0116 Table 1
Responder Rates [n (%)] on Patient ‘s
Global Assessment of Ankle Injury *
Patient’s Ankle Pain (VAS), mm**
Mean (SE)
CelecoxibIbuprofenPlaceboCelecoxibIbuprofenPlacebo
Baseline§ ......68.5 (14.1)68.2 (14.8)71.3 (12.1)
Day 4 99 (67%) 110 (71%)77 (55%)35.3 (1.6) 36.6 (1.6)42.4 (1.6)
Day 8 121 (82%) 126 (81%)101 (72%)23.3 (1.8) 24.3 (1.8)31.2 (1.8)
Day 11 133 (90%)142 (92%)124 (88%)15.6 (1.8) 15.7 (1.8)19.9 (1.8)
CelecoxibNaproxenPlaceboCelecoxibNaproxenPlacebo
Baseline ......67.6 (14.5)67.5 (13.1)..
Day 4 139 (71%) 142 (72%)..31.9 (2.0) 29.0 (1.9)..
Day 8 175 (89%) 178 (90%)..15.0 (1.7) 15.3 (1.7)..
  • * Improved by >/= 1 grade on 5-pt scale from 1 (very good) to 5 (very poor);

  • ** covariate-adjusted;

  • celecoxib not inferior to ibuprofen or naproxen based on 95% CI;

  • p >/= 0.51;

  • § VAS score = Mean (SD).